![]() |
市场调查报告书
商品编码
1762327
胎盘市场,规模,占有率,趋势,产业分析报告:类别,各用途,各地区,2025年~2034年的市场预测Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034 |
根据 Polaris Market Research 的最新研究,预计到 2034 年,全球胎盘市场规模将达到 14.0487 亿美元。该报告深入分析了当前的市场动态,并分析了未来的市场成长。
胎盘组织及其萃取物在生殖医学中用于促进子宫健康、提高胚胎着床率并增强整体生育能力。接受体外受精 (IVF) 等辅助生殖技术 (ART) 的夫妇越来越多地选择基于胎盘的治疗来提高受孕几率。临床研究表明,胎盘萃取物中的生物活性化合物可以改善子宫内膜容受性,从而提高胚胎着床的成功率。由于生活方式改变、压力和受孕延迟等因素导致不孕不育率持续上升,对胎盘衍生不孕症治疗等创新解决方案的需求预计将增长。因此,胎盘在生育治疗的应用日益广泛,促进了胎盘市场的成长。
人们对胎盘在皮肤病学、毛髮学和生殖医学应用的认识不断提高,并持续刺激了需求。斑秃越来越普遍,尤其是在女性和某些种族中,这增加了对利用胎盘再生特性的先进疗法的需求。正在进行的科学研究正在增强胎盘产品的功效,扩大其在医疗和化妆品领域的应用。
随着医疗和化妆品行业对胎盘衍生产品的需求不断增长,胎盘市场正在迅速扩张。从抗衰老护肤到护髮和生育治疗,胎盘萃取物的应用正在推动创新和投资。人们对天然、科学支持的解决方案日益增长的偏好,刺激了对胎盘的需求。各公司不断开发新的配方,推动市场扩张。持续的进步使胎盘市场在美容、健康和保健行业中始终占据重要地位。
按类型划分,由于猪胎盘用途广泛且易于获取,2024年猪胎盘占据了胎盘市场占有率的主导地位。猪胎盘因其富含胶原蛋白、蛋白质和活性胜肽,已成为市场上的宝贵资源。
按应用划分,预计製药领域在预测期内的复合年增长率最高。在製药领域,胎盘萃取物因其治疗特性而备受研究。其富含生长因子、细胞激素和细胞外囊泡等生物活性分子,使其成为治疗应用的有希望的候选材料。
由于对胎盘类化妆品、膳食补充剂和药品的需求不断增长等因素,北美在 2024 年占据了全球胎盘市场收入占有率的主导地位。
由于肌肉营养不良症等罕见疾病的盛行率上升以及对胎盘补充剂的需求不断增长,预计未来几年亚太市场将实现最高的复合年增长率。
The global placenta market size is expected to reach USD 1,404.87 million by 2034, according to a new study by Polaris Market Research. The report "Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Placental tissues and extracts are utilized in reproductive medicine to enhance uterine health, improve embryo implantation rates, and support overall fertility. Couples undergoing assisted reproductive technologies (ART), such as in-vitro fertilization (IVF), are increasingly turning to placenta-based treatments to enhance their chances of conception. Clinical research suggests that bioactive compounds found in placental extracts improve endometrial receptivity, making embryo implantation more successful. As infertility rates continue to rise due to factors such as lifestyle changes, stress, and delayed pregnancies, the need for innovative solutions such as placenta-derived fertility treatments is expected to grow. Thus, the expanding use of the placenta in fertility treatments is contributing to placenta market growth.
The rising awareness of placenta applications in dermatology, trichology, and reproductive medicine continues to fuel demand. With alopecia areata becoming more prevalent, particularly among women and certain ethnic groups, the need for advanced treatments utilizing the placenta's regenerative properties is growing. Ongoing scientific research is enhancing the effectiveness of placenta-based products, broadening their use across medical and cosmetic fields.
The placenta market is expanding rapidly as demand for placenta-derived products grows across the medical and cosmetic industries. From antiaging skincare to hair care and fertility treatments, the use of placental extracts is driving innovation and investment. The increasing preference for natural and scientifically backed solutions is fueling the placenta market demand. Companies are continuously developing new formulations, driving the market expansion. Ongoing advancements keep the market a significant player in the beauty, health, and wellness industries.
Based on type, the porcine segment dominated the placenta market share in 2024 due to its versatility and availability of porcine placenta. Porcine (pig) placenta is emerging as a valuable resource in the market, owing to its rich composition of collagen, proteins, and bioactive peptides.
The pharmaceuticals segment, by application, is estimated to register the highest CAGR during the forecast period. In the pharmaceutical segment, placental extracts have been explored for their therapeutic properties. The rich composition of bioactive molecules such as growth factors, cytokines, and extracellular vesicles makes placental extracts promising candidates for therapeutic applications.
North America dominated the global placenta market revenue share in 2024 due to factors such as increasing demand for placenta-based cosmetics, health supplements, and pharmaceutical products.
The market in Asia Pacific is expected to register the highest CAGR in the coming years owing to rising prevalence of rare diseases such as muscular dystrophy and growing demand for placenta-based supplements.
A few global key market players are Japan Natural Laboratories Co., Ltd.; Japan Bio Products Co., Ltd.; Albert David Limited; Atlanta Placenta Encapsulation; MIMEDX Group, Inc.; PURTIER Placenta; The Placenta Company; Smith and Nephew; Mommy Made Encapsulation; and Nubloom LLC.
Polaris Market Research has segmented the placenta market report on the basis of type, application, and region:
By Type Outlook (Revenue, USD Million, 2020-2034)
Porcine
Equine
Ovine
Others
By Application Outlook (Revenue, USD Million, 2020-2034)
Pharmaceuticals
Cosmetics
Supplements
Others
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
Israel
UAE
Rest of Middle East & Africa
Latin America
Brazil
Mexico
Argentina
Rest of Latin America